Not So Different: A Podcast From The Center For Biosimilars

S5 Ep1: Dr. Sonia Oskouei Discusses the US Launch of Byooviz, the First Ophthalmology Biosimilar

Informações:

Sinopsis

Show notes: To learn more about the US launch of Byooviz, click here. To read more about the anticipation for ophthalmology biosimilars, click here. To read more of Dr. Oskouei’s comments on “Round 2,” click here. To learn more about the EU approval of Byooviz, click here. To learn more about the Canadian approval of Byooviz, click here. To read more on the anticipation for aflibercept biosimilars, click here.